Medicines labeled for the same conditions
Alternatives to mirabegron
7 other medicines are given the same way (oral) and in the same FDA class as mirabegron or labeled mainly for the same use (overactive bladder); 1 is in its class, beta3-adrenergic agonists: vibegron; the others include 5 cholinergic muscarinic antagonists (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $16.46 per Gemtesa 75 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as mirabegron?
Overactive bladder lists all 9 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Mirabegronbeta3-adrenergic agonist | this medicine | 8 labelers | $9.39 per tablet 50 mg tablet | No | No current entry |
| Vibegronbeta3-adrenergic agonist · same class | Overactive bladder | none listed | $16.46 per tablet 75 mg tablet | No | No current entry |
| Oxybutynincholinergic muscarinic antagonist | Overactive bladder | 41 labelers | $0.048 per tablet 5 mg tablet | No | No current entry |
| Solifenacincholinergic muscarinic antagonist | Overactive bladder | 20 labelers | $0.162 per tablet 10 mg tablet | No | No current entry |
| Tolterodinecholinergic muscarinic antagonist | Overactive bladder | 14 labelers | $0.268 per capsule 2 mg capsule | No | No current entry |
| Trospiumcholinergic muscarinic antagonist | Overactive bladder | 20 labelers | $0.211 per tablet 20 mg tablet | No | No current entry |
| Fesoterodine | Overactive bladder | 11 labelers | $0.794 per tablet 4 mg tablet | No | No current entry |
| Darifenacincholinergic muscarinic antagonist | Overactive bladder | 8 labelers | $0.432 per tablet 15 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Mirabegron: the full record
- label, generics, price, shortages, recalls
- Mirabegron vs oxybutynin
- two records side by side
- Mirabegron vs solifenacin
- two records side by side
- Mirabegron vs tolterodine
- two records side by side
- Mirabegron vs trospium
- two records side by side